Esophageal Adenocarcinoma Clinical Trials in New Hyde Park, New York

4 studies are recruiting for esophageal adenocarcinoma in New Hyde Park, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Sigvotatug Vedotin in Advanced Solid Tumors

    This trial will look at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe for people who have solid tumors. It will study sigvotatug vedotin to find out what its side effects are. A side effect is anything the drug …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park, New York
    Locations
    158 in total
    Run by
    Seagen, a wholly owned subsidiary of Pfizer

    See if you can join NCT04389632 on ClinicalTrials.gov

  2. Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

    The purpose of this research study is to learn about the best approach to sample patients with known or suspected Barrett's esophagus (BE) by comparing the standard Seattle biopsy protocol to sampling using wide area transepithelial sampling (WATS3D). Barrett's esophagus is a common condition that …

    Stage
    Not phased
    Ages
    18 to 89
    Site
    Long Island Jewish Medical Center, New Hyde Park, New York
    Locations
    14 in total
    Run by
    University of Colorado, Denver

    See if you can join NCT05530343 on ClinicalTrials.gov

  3. Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples

    This clinical trial evaluates the use of cytosponge, a minimally invasive collection device, for the detection of Barrett's esophagus (BE) in patients undergoing endoscopy. Non-endoscopic swallowable encapsulate sponge cell collection devices combined with markers for BE/esophageal adenocarcinoma (…

    Stage
    Not phased
    Ages
    18 to 90
    Site
    Long Island Jewish Medical Center | Northwell Health, New Hyde Park, New York
    Locations
    5 in total
    Run by
    Mayo Clinic

    See if you can join NCT06071845 on ClinicalTrials.gov

  4. Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma

    This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma detection, in a screening population, with and without chronic gastroesophageal reflux disease.

    Stage
    Not phased
    Ages
    18 to 90
    Site
    Northwell Health, New Hyde Park, New York
    Locations
    9 in total
    Run by
    Mayo Clinic

    See if you can join NCT03961945 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.